| MR编号 | ES/V/0162/001 |
|---|
| 药品名称 | HIPRAGUMBORO CW |
|---|
| 活性成分 | - Live Infectious Bursal Disease Virus, strain CH/80 3.5 log10 CCID50
- Live Infectious Bursal Disease Virus, strain CH/80 5.5 log10 CCID50
|
|---|
| 剂型 | Oral lyophilisate |
|---|
| 上市许可持有人 | LABORATORIOS HIPRA S.A.
Avda. La Selva 135
17170 Amer (Girona)
SPAIN |
|---|
| 参考成员国 - 产品名称 | Spain (ES) HIPRAGUMBORO CW |
|---|
| 互认成员国 - 产品名称 | - Ireland (IE)
- Estonia (EE)
- Latvia (LV)
- Lithuania (LT)
- Sweden (SE)
- Norway (NO)
- Germany (DE)
Hipragumboro CW - Denmark (DK)
Hipragumboro cw - Belgium (BE)
Hipragumboro CW - Netherlands (NL)
Hipragumboro CW - United Kingdom (Northern Ireland) (XI)
- Austria (AT)
- France (FR)
HIPRAGUMBORO CW - Italy (IT)
- Slovakia (SK)
|
|---|
| 许可日期 | 2011/06/14 |
|---|
| 最近更新日期 | 2024/04/19 |
|---|
| 药物ATC编码 | - QI01AD09 avian infectious bursal disease virus (gumboro disease)
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|